Table 4

Neuronal autoantibody frequency in 201 patients with thymoma or thymic carcinoma

PatientsGanglionic AChR antibody (%)VGKC antibody (%)GAD65 antibody (%)CRMP-5-IgG or ANNA-1 (%)Any neuronal antibody (%)
Clinical subgroupNo.
MG only1038*13*15*18*43*
Other neurological disorder (± MG)§3719*32543078
No neurological diagnosis6181321741
Healthy subjects0280
(refs. 26 , 31 )(ref. 33 )(ref. 29 )(refs. 23 , 34 )
  • * No difference in seroprevalence compared with patients without a neurological diagnosis.

  • Seroprevalence significantly higher than patients without another neurological disorder; P < 0.05.

  • Seroprevalence significantly higher than patients without any neurological disorder; P < 0.0001.

  • § Twenty-three had MG.